The subspecialty of retina has seen a recent boom in advances pertaining to imaging, surgery, and medications for retinal diseases. Retinal Physician covered these new technologies and data on studies of new medications throughout 2018. Below is a list of 10 of the most read articles from the magazine last year.

1. Ocular Inflammation After Intravitreal Injections
A review of data on incidence and implications.
By KARL G. CSAKY, MD, PHD

2. Role of OCT Angiography in Neovascular AMD
Benefits in diagnosis and clinic workflow.
By VISHAL S. PARIKH, MD • SABIN DANG, MD • GAURAV K. SHAH, MD

3. Wet AMD in 2018: Drugs in Development
Research efforts are going beyond targeting VEGF.
By ASHISH SHARMA, MD • FRANCESCO BANDELLO, MD, FEBO • BARUCH D. KUPPERMANN, MD • DEEPIKA MAKAM, DNB

4. Practical Pearls for OCTA Image Interpretation
Become familiar with common challenges to overcome pitfalls.
By CAROLINE R. BAUMAL, MD

5. Upcoming Advances in Optical Coherence Tomography Angiography
Improvements could make OCTA a mainstay for retinal imaging.
By MALVIKA ARYA, BS • NADIA K. WAHEED, MD, MPH

6. OCT Angiography: An Economic and Ethical Dilemma for Ophthalmologists in the United States
Retina specialists have the responsibility of educating regulatory bodies.
By PHILIP J. ROSENFELD MD, PHD • SRINIVAS R. SADDA, MD • NADIA K. WAHEED, MD

7. Decoding EVEREST II and PLANET
Combination treatment for PCV could reduce cost and treatment burden.
By SUMIT RANDHIR SINGH, MD • JAY CHHABLANI, MD

8. Faricimab Shows Potential for 16-Week Dosing
Initial data presented from Genentech’s STAIRWAY study.
By Jerry Helzner, contributing editor

9. The Age-Related Eye Disease Study (AREDS) and AREDS 2 Supplements in 2018
Translation of research into real-world patient benefit is the goal.
By EMILY Y. CHEW, MD

10. What’s New in Vitreoretinal Instrumentation?
New designs, cut rates, and port migration aim to increase efficiency.
By CAROLINA L. M. FRANCISCONI, MD • DAVID R. CHOW, MD, FRCSC